Form 4: Robert Ortenzio, Executive Chairman of Select Medical Holdings, Reports Changes in Beneficial Ownership

Robert Ortenzio, Executive Chairman of Select Medical Holdings, filed a Form 4 disclosing changes in beneficial ownership of company stock due to tax withholding obligations and indirect ownership through trusts.

Summary

• Robert A. Ortenzio, Executive Chairman of Select Medical Holdings, reported changes in his beneficial ownership of the company's stock.
• The report, filed on August 5, 2024, details a transaction on August 3, 2024, where 87,880 shares of common stock were disposed of to satisfy tax withholding obligations related to the vesting of restricted stock at a price of $34.18 per share.
• Following the transaction, Ortenzio directly owns 6,831,788 shares of common stock.
• He also indirectly owns shares through several trusts, including the Robert A. Ortenzio Descendants Trust (1,279,000 shares), the Rocco A. Ortenzio Separate Exempt Descendants Trust (3,804,805 shares), and three 2014 trusts for Bryan A. Ortenzio, Kevin M. Ortenzio, and Madeline G. Ortenzio (280,415 shares each).

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing changes in beneficial ownership. It doesn't inherently convey positive or negative sentiment, as it simply reports transactions.

Management Comments

• The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in company stock. It is common for executives to sell shares to cover tax obligations related to vesting equity awards.

Stakeholder Impact

• The transaction has a minimal impact on shareholders, as it is a routine disposal of shares for tax purposes and does not indicate a change in the executive's long-term commitment to the company.

Key Dates